Search Results

Plandai Biotechnology, Inc. announces the rescission of a material definitive agreement with Good Salt, LLC due to the material failure of consideration in the transaction.

Plandai Biotechnology, Inc. (OTC PINK:PLPL) announces it has entered into a binding memorandum of understanding to close a share exchange agreement with Good Salt, LLC, a Florida limited liability company.

Plandai Biotechnology, Inc. announce the completion of a share exchange agreement whereby PLPL shall acquire one hundred percent of the issued and outstanding ByoPlanet Interests and ByoPlanet’s fixed tangible and intangible assets in exchange for all authorized, issued, and outstanding PLPL Preferred Common Shares and Common Stock.

Plandai Biotechnology, Inc. announces the termination of its previously announced asset acquisition agreement with EV Hotel Corp., a Georgia corporation.

Plandai Biotechnology, Inc. announces its entry into a non-binding letter of intent with EV Hotel Corp., a Georgia corporation.

Plandai Biotechnology, Inc. announces the termination of its non-binding letter of intent dated May 23, 2022, with Ms. Jessie Chiang, license holder of the worldwide rights, exclusive of Taiwan, of the Puriblood Leukocyte Reduction Blood Filtration System.

Plandai Biotechnology is pleased to announce a comprehensive rebranding initiative following the successful completion of its share exchange agreement with ByoPlanet, LLC.

ByoPlanet, a wholly owned subsidiary of Plandai Biotechnology, Inc., a leading innovator in revolutionary cleaning technology, announced the completion of a third-party valuation firm’s estimates of ByoPlanet’s business and assets based on ByoPlanet’s unaudited financial statements and internal projections.